Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia.
Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.
Goodbye to all that: a short history of CCSVI.
Inflammatory bowel disease: An increased risk factor for neurologic complications.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 8. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
Trial and error in clinical studies: lessons from ATAMS.
HLA associations in South Asian multiple sclerosis.
Facial and Bodily Emotion Recognition in Multiple Sclerosis: The Role of Alexithymia and Other Characteristics of the Disease.
Human oligodendrocytes in remyelination research.
[Anesthetic management of a Dialysis Patient with Chronic Inflammatory Demyelinating Polyneuropathy].
Risk factors for falls in multiple sclerosis: an observational study.
Simvastatin: Multiple Sclerosis.
Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Cdon, a cell surface protein, mediates oligodendrocyte differentiation and myelination.
Postural control strategy during standing is altered in patients with multiple sclerosis.
Pages
« first
‹ previous
…
403
404
405
406
407
408
409
410
411
…
next ›
last »